SARcode $44mn for PhIII dry eye study
19 July 2011
Nancy Faigen
Please Login to read the full article.
19 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- China must clean up act before it can join fully in global pharma, says KPMG report
- Derma Sciences raises $29M, as CEO claims diabetic foot ulcer agent could be global $900M drug
